Curcumin Modulates Paraquat-Induced Epithelial to Mesenchymal Transition by Regulating Transforming Growth Factor-β (TGF-β) in A549 Cells.


Journal

Inflammation
ISSN: 1573-2576
Titre abrégé: Inflammation
Pays: United States
ID NLM: 7600105

Informations de publication

Date de publication:
Aug 2019
Historique:
pubmed: 28 4 2019
medline: 14 1 2020
entrez: 28 4 2019
Statut: ppublish

Résumé

Paraquat (PQ), a widely used potent herbicide, generates superoxide anions and other free radicals, leading to severe toxicity and acute lung injury. PQ induces pulmonary fibrosis through epithelial to mesenchymal transition (EMT) characterized by increased number of myofibroblasts. Time-dependent PQ-induced EMT has been evaluated in present investigation where intracellular ROS levels were significantly enhanced after 24 h of PQ intoxication. Anti-inflammatory effects of curcumin have been studied where alveolar epithelial cells (A549 cells) were incubated with curcumin (30 μΜ) for 1 and 3 h before PQ intoxication (700 μM). Western blot and immunocytochemistry studies revealed that pretreatment of A549 cells with curcumin for 3 h before PQ exposure has maintained E-cadherin expression and inhibited PQ induced α-smooth-muscle actin (α-SMA) expression. Transforming growth factor-β (TGF-β) that seems to be involved in PQ-induced EMT was enhanced after PQ intoxication, but curcumin pretreatment has effectively inhibited its expression. Immunostaining studies have shown that curcumin pretreatment has significantly reduced matrix metalloproteinase-9 (MMP-9) expressions, which were elevated after PQ intoxication. These results demonstrate that curcumin can regulate PQ-induced EMT by regulating the expression of TGF-β.

Identifiants

pubmed: 31028577
doi: 10.1007/s10753-019-01006-0
pii: 10.1007/s10753-019-01006-0
doi:

Substances chimiques

Cadherins 0
Herbicides 0
Transforming Growth Factor beta 0
Matrix Metalloproteinase 9 EC 3.4.24.35
Curcumin IT942ZTH98
Paraquat PLG39H7695

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1441-1455

Références

Eur J Cancer. 1999 Apr;35(4):664-71
pubmed: 10492644
QJM. 2000 Nov;93(11):715-31
pubmed: 11077028
Methods. 2001 Dec;25(4):386-401
pubmed: 11846608
Annu Rev Physiol. 2003;65:669-95
pubmed: 12428023
J Clin Invest. 2003 Dec;112(12):1776-84
pubmed: 14679171
Respirology. 2003 Dec;8(4):432-46
pubmed: 14708552
Eur Respir J. 2004 Feb;23(2):327-33
pubmed: 14979512
Respir Care. 2005 Mar;50(3):383-5
pubmed: 15779152
Respir Res. 2005 Jun 09;6:56
pubmed: 15946381
Am J Respir Cell Mol Biol. 2006 May;34(5):520-2
pubmed: 16618786
Proc Am Thorac Soc. 2006 Jun;3(4):377-82
pubmed: 16738204
Proc Am Thorac Soc. 2006 Jul;3(5):413-7
pubmed: 16799084
Proc Natl Acad Sci U S A. 2006 Aug 29;103(35):13180-5
pubmed: 16924102
Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L525-34
pubmed: 17631612
Crit Rev Toxicol. 2008;38(1):13-71
pubmed: 18161502
Respir Physiol Neurobiol. 2008 Nov 30;163(1-3):3-16
pubmed: 18565804
J Clin Invest. 2009 Jun;119(6):1420-8
pubmed: 19487818
Am J Respir Crit Care Med. 2009 Oct 1;180(7):657-65
pubmed: 19556518
Am J Physiol Lung Cell Mol Physiol. 2010 Jun;298(6):L715-31
pubmed: 20363851
Am J Respir Cell Mol Biol. 2011 Aug;45(2):189-201
pubmed: 21330463
Neurochem Int. 2011 Aug;59(2):297-308
pubmed: 21704098
Drug Saf. 1990 Jul-Aug;5(4):243-51
pubmed: 2198050
Toxicol Lett. 2012 Jan 25;208(2):101-7
pubmed: 22079615
Curr Opin Pulm Med. 2012 Sep;18(5):517-23
pubmed: 22854509
Infect Immun. 2013 Jan;81(1):381-9
pubmed: 23147039
Biochim Biophys Acta. 2013 Jul;1832(7):911-21
pubmed: 23499992
Nat Rev Mol Cell Biol. 2014 Mar;15(3):178-96
pubmed: 24556840
Eur Respir J. 2015 Apr;45(4):1150-62
pubmed: 25700381
PLoS One. 2015 Mar 23;10(3):e0120192
pubmed: 25799450
Mol Med Rep. 2015 Dec;12(6):7979-84
pubmed: 26499763
World J Gastroenterol. 2016 May 21;22(19):4695-706
pubmed: 27217701
Inflammopharmacology. 2016 Dec;24(6):335-345
pubmed: 27766504
Am J Cancer Res. 2017 Jan 01;7(1):125-133
pubmed: 28123853
Evid Based Complement Alternat Med. 2017;2017:7876064
pubmed: 28203261
Toxicol Appl Pharmacol. 1988 May;93(3):472-83
pubmed: 3285521
Am J Pathol. 1973 Feb;70(2):175-98
pubmed: 4566990
J Immunol Methods. 1983 Dec 16;65(1-2):55-63
pubmed: 6606682
Acta Anat (Basel). 1995;154(1):8-20
pubmed: 8714286

Auteurs

Namitosh Tyagi (N)

Department of Zoology, MMV, Banaras Hindu University, Varanasi, 221005, India.

D K Singh (DK)

Department of Physics, Udai Pratap Autonomous College, Varanasi, 221002, India.

D Dash (D)

Department of Biochemistry, Institute of Medical Sciences, Banaras Hindu University, Varanasi, 221005, India.

Rashmi Singh (R)

Department of Zoology, MMV, Banaras Hindu University, Varanasi, 221005, India. rashmirs98@rediffmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH